Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Phase II/III Trial of Second Line Chemotherapy Comparing CPT-11 Monotherapy Versus S-1/CPT-11 Combination for S-1 Refractory Gastric Cancer

NCT00639327 is registered in ClinicalTrials.gov with Japan Clinical Cancer Research Organization as lead sponsor.

NCT NCT00639327
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00639327 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Phase II/III Trial of Second Line Chemotherapy Comparing CPT-11 Monotherapy Versus S-1/CPT-11 Combination for S-1 Refractory Gastric Cancer
Lead sponsor
Japan Clinical Cancer Research Organization
Phase
Phase 2/3
Overall status
Completed
Start date
March 31, 2008
Completion date
June 30, 2011
Enrollment
300 (estimated)
Sites
86

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer